טוען...
Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia
OBJECTIVE: An immediate-release formulation of gabapentin is approved for treatment of postherpetic neuralgia (PHN). This formulation, however, requires multiple daily dosing, usually three times per day, and is associated with a high incidence of somnolence and dizziness. We assessed the tolerabili...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3392710/ https://ncbi.nlm.nih.gov/pubmed/22792006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S32562 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|